Tari A. King

36.8k total citations · 3 hit papers
288 papers, 9.4k citations indexed

About

Tari A. King is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Tari A. King has authored 288 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 222 papers in Cancer Research, 135 papers in Oncology and 125 papers in Pathology and Forensic Medicine. Recurrent topics in Tari A. King's work include Breast Cancer Treatment Studies (202 papers), Breast Lesions and Carcinomas (117 papers) and Breast Implant and Reconstruction (52 papers). Tari A. King is often cited by papers focused on Breast Cancer Treatment Studies (202 papers), Breast Lesions and Carcinomas (117 papers) and Breast Implant and Reconstruction (52 papers). Tari A. King collaborates with scholars based in United States, Canada and Italy. Tari A. King's co-authors include Monica Morrow, Rita A. Sakr, Larry Norton, Michelle Stempel, George M. Fuhrman, John S. Bolton, Mary Morrogh, Elizabeth Comen, Sujata Patil and Elizabeth A. Mittendorf and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Tari A. King

265 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

2013 855 citations Rita A. Sakr, Tari A. King et al. profile →
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung

2011 601 citations Tari A. King et al. profile →
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer

2022 147 citations Paolo Tarantino, Qingchun Jin et al. profile →

Peers

Countries citing papers authored by Tari A. King

Since Specialization

Citations

This map shows the geographic impact of Tari A. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tari A. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tari A. King more than expected).

Fields of papers citing papers by Tari A. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tari A. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tari A. King. The network helps show where Tari A. King may publish in the future.

Co-authorship network of co-authors of Tari A. King

This figure shows the co-authorship network connecting the top 25 collaborators of Tari A. King. A scholar is included among the top collaborators of Tari A. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tari A. King. Tari A. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer—Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update 2024 ·Journal of Clinical Oncology ·Rachel A. Freedman, Jennifer L. Caswell‐Jin, Michael J. Hassett, Mark R. Somerfield, Sharon H. Giordano, (unknown), Mariana Chávez‐MacGregor, Amy Comander, Zoneddy Dayao, Andrea Eisen, (unknown), Stephanie L. Graff, Tari A. King, Gary H. Lyman, (unknown), Cheryl Perkins, Melinda L. Telli, Maureen Trudeau, Antonio C. Wolff, (unknown)	18
2	Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆ 2024 ·ESMO Open ·Akshara Singareeka Raghavendra, (unknown), Qingchun Jin, (unknown), Melissa Grimm, Melissa E. Hughes, Mathew Cherian, (unknown), (unknown), Paolo Tarantino, Elizabeth A. Mittendorf, Tari A. King, Vicente Valero, Debu Tripathy, Sara M. Tolaney, Nabihah Tayob, Nancy U. Lin, Daniel G. Stover, Carlos H. Bárcenas, Ana C. Garrido-Castro	4
3	Arm morbidity and financial difficulty in breast cancer survivors 2024 ·Journal of Cancer Survivorship ·Sara P. Myers, Alison Laws, Laura S. Dominici, Mirelle Lagendijk, (unknown), Elizabeth A. Mittendorf, Tari A. King	1
4	Association of Surgery With Frailty Status in Older Women With Early-Stage Breast Cancer 2023 ·JAMA Surgery ·Christina A. Minami, Ginger Zhe Jin, Rachel A. Freedman, Mara A. Schonberg, Tari A. King, Elizabeth A. Mittendorf	6
5	Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I–III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial 2023 ·Annals of Surgical Oncology ·Charity C. Glass, (unknown), Rachel A. Freedman, Erica L. Mayer, (unknown), Mariana Chávez‐MacGregor, Tari A. King, Elizabeth A. Mittendorf, Olga Kantor	0
6	Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor–Positive Breast Cancer: Implications for Guidance and Reimbursement 2023 ·JCO Oncology Practice ·Dario Trapani, Qingchun Jin, Caroline Block, Rachel A. Freedman, Nancy U. Lin, Paolo Tarantino, Elizabeth A. Mittendorf, Tari A. King, Susan C. Lester, Jane E. Brock, Nabihah Tayob, Craig A. Bunnell, Sara M. Tolaney, Harold J. Burstein	1
7	Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy 2022 ·Breast Cancer Research and Treatment ·Anna Weiss, (unknown), (unknown), (unknown), (unknown), Faina Nakhlis, Laura S. Dominici, Elizabeth A. Mittendorf, Tari A. King	9
8	Racial‐ethnic variations in phyllodes tumors among a multicenter United States cohort 2022 ·Journal of Surgical Oncology ·(unknown), Samantha M. Thomas, (unknown), Tina J. Hieken, Kandice K. Ludwig, Lisa K. Jacobs, Megan E. Miller, Kristalyn K. Gallagher, Jasmine Wong, Heather B. Neuman, (unknown), Taryn E. Hassinger, Tari A. King, E. Shelley Hwang, James W. Jakub, Laura H. Rosenberger	0
9	Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer 2021 ·PubMed ·Alison Laws, Ana C. Garrido-Castro, Philip D. Poorvu, Eric P. Winer, Elizabeth A. Mittendorf, Tari A. King	6
10	The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network 2020 ·Cancer Epidemiology Biomarkers & Prevention ·Yujing J. Heng, Susan E. Hankinson, Jun Wang, Ludmil B. Alexandrov, Christine B. Ambrosone, Victor Piana de Andrade, Adam Brufsky, Fergus J. Couch, Tari A. King, Francesmary Modugno, Celine M. Vachon, A. Heather Eliassen, Rulla M. Tamimi, Peter Kraft	6
11	Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update 2020 ·Journal of Clinical Oncology ·Neelima Denduluri, Mark R. Somerfield, Mariana Chávez‐MacGregor, Amy Comander, Zoneddy Dayao, Andrea Eisen, Rachel A. Freedman, (unknown), Stephanie L. Graff, Michael J. Hassett, Tari A. King, Gary H. Lyman, (unknown), Raquel Nunes, Cheryl Perkins, Melinda L. Telli, Maureen Trudeau, Antonio C. Wolff, Sharon H. Giordano	76
12	Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients 2020 ·Breast Cancer Research and Treatment ·Oluwadamilola M. Fayanju, Yi Ren, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Jeremy Force, Gita Suneja, Gayathri R. Devi, Tari A. King, Faina Nakhlis, Terry Hyslop, E. Shelley Hwang	21
13	Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma 2018 ·Clinical Cancer Research ·Ju Youn Lee, Michail Schizas, Felipe C. Geyer, Pier Selenica, Salvatore Piscuoglio, Rita A. Sakr, Charlotte K.Y. Ng, (unknown), Russell Towers, Dilip D. Giri, Victor Piana de Andrade, Anastasios D. Papanastasiou, Agnès Viale, Reuben S. Harris, David B. Solit, Britta Weigelt, Jorge S. Reis‐Filho, Tari A. King	39
14	Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues 2018 ·Breast Cancer Research and Treatment ·Yujing J. Heng, Jun Wang, Thomas U. Ahearn, Susan B. Brown, Xuehong Zhang, Christine B. Ambrosone, Victor Piana de Andrade, Adam Brufsky, Fergus J. Couch, Tari A. King, Francesmary Modugno, Celine M. Vachon, Natalie Dupré, Montserrat García‐Closas, Melissa A. Troester, David J. Hunter, A. Heather Eliassen, Rulla M. Tamimi, Susan E. Hankinson, Andrew H. Beck	22
15	Preoperative Psychosocial and Psychophysical Phenotypes as Predictors of Acute Pain Outcomes After Breast Surgery 2018 ·Journal of Pain ·Kristin L. Schreiber, Nantthasorn Zinboonyahgoon, Xinling Xu, Tara Spivey, Tari A. King, Laura S. Dominici, Ann H. Partridge, Mehra Golshan, Gary R. Strichartz, R. Edwards	61
16	Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis 2016 ·Breast Cancer Research and Treatment ·Antonio Di Meglio, Rachel A. Freedman, Nancy U. Lin, William T. Barry, Otto Metzger, Nancy L. Keating, Tari A. King, Mario Roberto Sertoli, Francesco Boccardo, Eric P. Winer, Inês Vaz-Luís	31
17	Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020) 2015 ·Annals of Surgical Oncology ·Faina Nakhlis, Lauren Gilmore, Rebecca Gelman, Isabelle Bedrosian, Kandice K. Ludwig, Eunjoo Hwang, Shawna C. Willey, Clifford A. Hudis, J. Dirk Iglehart, Elizabeth Lawler, Nicole Ryabin, Mehra Golshan, Stuart J. Schnitt, Tari A. King	59
18	Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer 2014 ·Cancer Research ·Mary Jo Fackler, Zoila A. Lopez‐Bujanda, Christopher B. Umbricht, Wei Wen Teo, Soonweng Cho, Zhe Zhang, Kala Visvanathan, Stacie C. Jeter, Pedram Argani, Chenguang Wang, Jaclyn P. Lyman, Marina De Brot, James N. Ingle, Judy C. Boughey, Kandace P. McGuire, Tari A. King, Lisa A. Carey, Leslie Cope, Antonio C. Wolff, Saraswati Sukumar	118
19	PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ —Implications for Progression to Invasive Breast Carcinoma 2014 ·Clinical Cancer Research ·Rita A. Sakr, Britta Weigelt, Sarat Chandarlapaty, Victor Piana de Andrade, Elena Guerini‐Rocco, Dilip D. Giri, Charlotte K.Y. Ng, Catherine F. Cowell, Neal Rosen, Jorge S. Reis‐Filho, Tari A. King	39
20	Genomic Complexity and AKT Dependence in Serous Ovarian Cancer 2011 ·Cancer Discovery ·Aphrothiti J. Hanrahan, Nikolaus Schultz, Maggie L. Westfal, Rita A. Sakr, Dilip D. Giri, (unknown), (unknown), Narciso Olvera, Ellen V. Stevens, Qing‐Bai She, Carol Aghajanian, Tari A. King, Elisa de Stanchina, David R. Spriggs, Adriana Heguy, Barry S. Taylor, Chris Sander, Neal Rosen, Douglas A. Levine, David B. Solit	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact